Recently, Sun et al. reported that SFN also inhibits the growth of the ALDH+ subpopulation of the breast cancer stem cell line, SUM-159, via down regulation of the Wnt/β-catenin self-renewal pathway [8]. Here, SFN is linked to breast carcinoma.